Karen S. Slobod

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

Helen E. Heslop, Karen S. Slobod, Martin Pulé et al. · Blood · 2009 · 778 citations · Full text

Life Sciences, Hematology, Immunology +17

Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial

Shabir A. Madhi, Clare Cutland, Lisa Jose et al. · The Lancet Infectious Diseases · 2016 · 162 citations

Medicine, Immunology, Maternal Health +14

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

Robert S. Heyderman, Shabir A. Madhi, Neil French et al. · The Lancet Infectious Diseases · 2016 · 129 citations · Full text

Veterinary Medicine, Infectious Diseases, Maternal Health +17

Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults

Karen S. Slobod, Jerry L. Shenep, Jorge Luján‐Zilbermann et al. · Vaccine · 2004 · 128 citations

Life Sciences, Immunology, Infectious Diseases +13

Localization of CD4 ⁺ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing

Sherri L. Surman, Timothy Lockey, Karen S. Slobod et al. · Proceedings of the National Academy of Sciences · 2001 · 97 citations · Full text

Life Sciences, Immunology, Molecular Biology +17